Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M John Gill

Showing results (11-20 of 248) with videos related to

Pageof 25
Sort By:
AIDS Patient Care and Stds|July 17, 2008
Participation in HIV research: the importance of clinic contact factorsCatherine A Worthington, M John Gill
AIDS (London, England)|February 25, 2003
The impact on health-related quality of life of treatment interruptions in HIV-1-infected patientsHartmut B Krentz, M John Gill
AIDS Patient Care and Stds|November 7, 2015
The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV PatientsHartmut B Krentz, M John Gill
AIDS (London, England)|November 7, 2006
Costing implications of recent treatment interruption studiesM John Gill, Hartmut B Krentz
The Lancet. HIV|November 29, 2015
Mortality in migrants with HIV in western EuropeM John Gill, Hartmut B Krentz
Expert Review of Anti-Infective Therapy|April 21, 2011
Impact of current antiretroviral therapies on neuroAIDSPornpun Vivithanaporn, M John Gill, Christopher Power
Lancet (London, England)|November 10, 2019
Protecting the health of children moving to CanadaTaj Jadavji, Raynell Lang, M John Gill
Neurologic Clinics|July 29, 2008
HIV infection of the central nervous system: clinical features and neuropathogenesisLysa Boissé, M John Gill, Christopher Power
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 11, 2007
The oncology impact of highly active antiretroviral therapyRichard Schlichemeyer, Carole Chambers, M John Gill
AIDS Patient Care and Stds|June 21, 2003
Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIVJinell B Mah Ming, M John Gill
Pageof 25

Showing results (11-20 of 248) with videos related to

Sort By:
Pageof 25
AIDS Patient Care and Stds|July 17, 2008
Participation in HIV research: the importance of clinic contact factorsCatherine A Worthington, M John Gill
AIDS (London, England)|February 25, 2003
The impact on health-related quality of life of treatment interruptions in HIV-1-infected patientsHartmut B Krentz, M John Gill
AIDS Patient Care and Stds|November 7, 2015
The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV PatientsHartmut B Krentz, M John Gill
AIDS (London, England)|November 7, 2006
Costing implications of recent treatment interruption studiesM John Gill, Hartmut B Krentz
The Lancet. HIV|November 29, 2015
Mortality in migrants with HIV in western EuropeM John Gill, Hartmut B Krentz
Expert Review of Anti-Infective Therapy|April 21, 2011
Impact of current antiretroviral therapies on neuroAIDSPornpun Vivithanaporn, M John Gill, Christopher Power
Lancet (London, England)|November 10, 2019
Protecting the health of children moving to CanadaTaj Jadavji, Raynell Lang, M John Gill
Neurologic Clinics|July 29, 2008
HIV infection of the central nervous system: clinical features and neuropathogenesisLysa Boissé, M John Gill, Christopher Power
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 11, 2007
The oncology impact of highly active antiretroviral therapyRichard Schlichemeyer, Carole Chambers, M John Gill
AIDS Patient Care and Stds|June 21, 2003
Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIVJinell B Mah Ming, M John Gill
Pageof 25